New asthma inhaler drug tested in teens – early results show promise

NCT ID NCT07065331

Completed Symptom relief Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 21 times

Summary

This early-stage study tested a single inhaled dose of a new drug called AZD8630 in 10 teenagers with asthma. The goal was to see how the drug moves through the body and to check for any safety issues. Participants used a dry powder inhaler and were monitored for side effects and immune reactions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site

Bakersfield, California, 93301, United States
Research Site

Miami Lakes, Florida, 33014, United States
Research Site

Lafayette, Louisiana, 70508, United States
Research Site

Raleigh, North Carolina, 27607, United States
Research Site

Toledo, Ohio, 43617, United States
Research Site

Oklahoma City, Oklahoma, 73120, United States
Research Site

Spartanburg, South Carolina, 29303, United States
Research Site

Boerne, Texas, 78006, United States
Research Site

Salt Lake City, Utah, 84107, United States

Conditions

Explore the condition pages connected to this study.

ASTHMA